Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia.
J Koopman, … , J Soria, C Soria
J Koopman, … , J Soria, C Soria
Published April 1, 1993
Citation Information: J Clin Invest. 1993;91(4):1637-1643. https://doi.org/10.1172/JCI116371.
View: Text | PDF
Research Article

Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia.

  • Text
  • PDF
Abstract

The molecular defect in the abnormal fibrinogen Dusart (Paris V) that is associated with thrombophilia was determined by sequence analysis of genomic DNA that had been amplified using the polymerase chain reaction. The propositus was heterozygous for a single base change (C-->T) in the A alpha-chain gene, resulting in the amino acid substitution A alpha 554 Arg-->Cys. Restriction analysis of the amplified DNA derived from the family members showed that his father and his two sons were also heterozygous. Electron microscopic studies on fibrin formed from purified fibrinogen Dusart demonstrated fibers that were much thinner than in normal fibrin. In contrast to the previously observed defective binding of plasminogen, the binding of thrombospondin to immobilized fibrinogen Dusart was similar to that of normal fibrinogen. Immunoblot analysis of plasma fibrinogen demonstrated that a substantial part of the fibrinogen Dusart molecules were disulfide-linked to albumin. The plasma of the affected family members also contained fibrinogen-albumin complexes. Furthermore, small amounts of high molecular weight complexes containing fibrinogen were detected in all the heterozygous individuals. These data indicate that the molecular abnormality in fibrinogen Dusart (A alpha 554 Arg-->Cys) results in defective lateral association of the fibrin fibers and disulfide-linked complex formation with albumin, and is associated with a family history of recurrent thrombosis in the affected individuals.

Authors

J Koopman, F Haverkate, J Grimbergen, S T Lord, M W Mosesson, J P DiOrio, K S Siebenlist, C Legrand, J Soria, C Soria

×

Total citations by year

Year: 2024 2023 2021 2020 2019 2018 2017 2016 2015 2014 2013 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1996 1995 1994 1981 Total
Citations: 1 1 3 2 4 2 1 1 1 1 4 1 1 2 4 4 6 2 1 2 1 6 5 2 3 4 2 6 1 74
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (74)

Title and authors Publication Year
Fibrinogen post‐translational modifications are biochemical determinants of fibrin clot properties and interactions
Tenopoulou M
The Febs Journal 2024
Germline VWF/MPRIP and somatoplasm FGA variants synergically confer susceptibility to non-traumatic osteonecrosis of the femoral head.
Wang D, Gu L, Zheng J, Zhang Q, Xu Q, Li R, Song D, Ha C, Zhang Q, Yin H, Xu M, Wang H, Li W, Yuan Z, Yang C, Gu M
Scientific Reports 2023
Thromboses and Hemostasis Disorders Associated with Coronavirus Disease 2019: The Possible Causal Role of Cross-Reactivity and Immunological Imprinting
D Kanduc
2021
Dysfibrinogenemia—Potential Impact of Genotype on Thrombosis or Bleeding
MV Bor, S Feddersen, IS Pedersen, JJ Sidelmann, SR Kristensen
Seminars in thrombosis and hemostasis 2021
Venous Thrombosis and Thrombocyte Activity in Zebrafish Models of Quantitative and Qualitative Fibrinogen Disorders
RJ Fish, C Freire, CD Sanza, M Neerman-Arbez
International journal of molecular sciences 2021
The genetics of venous thromboembolism: a systematic review of thrombophilia families
Y Zhang, Z Zhang, S Shu, W Niu, W Xie, J Wan, Z Zhai, C Wang
Journal of Thrombosis and Thrombolysis 2020
Missing regions within the molecular architecture of human fibrin clots structurally resolved by XL-MS and integrative structural modeling
O Klykov, C van der Zwaan, AJ Heck, AB Meijer, RA Scheltema
Proceedings of the National Academy of Sciences 2020
Fibrinogen αC domain: Its importance in physiopathology
J Soria, S Mirshahi, SQ Mirshahi, R Varin, LL Pritchard, C Soria, M Mirshahi
Research and Practice in Thrombosis and Haemostasis 2019

c.259A>C in the fibrinogen gene of alpha chain (FGA) is a fibrinogen with thrombotic phenotype


O Salomon, O Barel, E Eyal, RS Ganor, Y Kleinbaum, M Shohat
The Application of Clinical Genetics 2019
Homocysteine Modification in Protein Structure/Function and Human Disease
H Jakubowski
Physiological reviews 2019
Thrombotic complications in adult patients with severe single coagulation factor or platelet defects – an overview
H Skaadel, Ø Bruserud
Expert Review of Hematology 2019
Human Fibrinogen: Molecular and Genetic Aspects of Congenital Disorders
G Tiscia, M Margaglione
International journal of molecular sciences 2018
Hereditary Fibrinogen Aα-Chain Amyloidosis in Asia: Clinical and Molecular Characteristics
M Yazaki, T Yoshinaga, Y Sekijima, F Kametani, N Okumura
International journal of molecular sciences 2018
VLITL is a major cross-β-sheet signal for fibrinogen Aα-chain frameshift variants
C Garnier, F Briki, B Nedelec, PL Pogamp, A Dogan, N Rioux-Leclercq, R Goude, C Beugnet, L Martin, M Delpech, F Bridoux, G Grateau, J Doucet, P Derreumaux, S Valleix
Blood 2017
Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications
Y Amri, C Kallel, M Becheur, R Dabboubi, M Elloumi, H Belaaj, S Kammoun, T Messaoud, P Moerloose, NE Toumi
Clinica Chimica Acta 2016
Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management
A Casini, M Neerman-Arbez, RA Ariëns, P Moerloose
Journal of Thrombosis and Haemostasis 2015
Natural history of patients with congenital dysfibrinogenemia
A Casini, M Blondon, A Lebreton, J Koegel, V Tintillier, E Maistre, P Gautier, C Biron, M Neerman-Arbez, P Moerloose
Blood 2014
Dusart Syndrome in a Scandinavian family characterized by arterial and venous thrombosis at young age
R Ramanathan, J Gram, S Feddersen, M Nybo, A Larsen, JJ Sidelmann
Scandinavian Journal of Clinical & Laboratory Investigation 2013
Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease: FIBA-derived peptides in AD
M Noguchi, T Sato, K Nagai, I Utagawa, I Suzuki, M Arito, N Iizuka, N Suematsu, K Okamoto, T Kato, N Yamaguchi, MS Kurokawa
International Journal of Geriatric Psychiatry 2013
Identification of N-homocysteinylation sites in plasma proteins
M Sikora, Ł Marczak, J Kubalska, AŁ Graban, H Jakubowski
Amino Acids 2013
Homocysteine in Protein Structure/Function and Human Disease
H Jakubowski
2013
Homocysteinylated fibrinogen forms disulfide-linked complexes with albumin
DL Sauls, M Warren, M Hoffman
Thrombosis Research 2011
Textbook of Hemophilia
A Goodeve
Textbook of Hemophilia 2010
Modification of fibrin structure as a possible cause of thrombolytic resistance
B Lipinski
Journal of Thrombosis and Thrombolysis 2009
Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BβGly15Cys (Hamamatsu II)
Y Kamijyo, M Hirota-Kawadobora, K Yamauchi, F Terasawa, T Honda, M Ikeya, N Okumura
Blood Coagulation & Fibrinolysis 2009
Common variation in the C-terminal region of the fibrinogen -chain: effects on fibrin structure, fibrinolysis and clot rigidity
R Ajjan, BC Lim, KF Standeven, R Harrand, S Dolling, F Phoenix, R Greaves, RH Abou-Saleh, S Connell, DA Smith, JW Weisel, PJ Grant, RA Ariens
Blood 2008
Dysfibrinogen Kagoshima with the amino acid substitution γThr-314 to Ile: Analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule
K Niwa, J Mimuro, M Miyata, T Sugo, T Ohmori, S Madoiwa, C Tei, Y Sakata
Thrombosis Research 2008
A new electrophoretic variant of fibrinogen associated with venous thromboembolism, fibrinogen Bordeaux A Arg439Cys
M Hanss, C Vergnes, L Rugeri, P Ffrench, PD Mazancourt
Journal of Thrombosis and Haemostasis 2008
Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias
M Hill, G Dolan
Haemophilia 2008
Structural analyses of fibrinogen amyloid fibrils
LC Serpell, M Benson, JJ Liepnieks, PE Fraser
Amyloid 2007
Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia
DL Sauls, EK Arnold, CW Bell, JC Allen, M Hoffman
Thrombosis Research 2007
NMR Solution Structure, Stability, and Interaction of the Recombinant Bovine Fibrinogen αC-Domain Fragment
RA Burton, G Tsurupa, RR Hantgan, N Tjandra, L Medved
Biochemistry 2007
Direct Evidence for Specific Interactions of the Fibrinogen αC-Domains with the Central E Region and with Each Other
RI Litvinov, S Yakovlev, G Tsurupa, OV Gorkun, L Medved, JW Weisel
Biochemistry 2007
Molecular weight fibrinogen variants determine angiogenesis rate in a fibrin matrix in vitro and in vivo
EL Kaijzel, P Koolwijk, MG van Erck, VW van Hinsbergh, MP de Maat
Journal of Thrombosis and Haemostasis 2006
New Insight into Alzheimer Disease: Demonstration of Fibrin(ogen)-serum Albumin Insoluble Deposits in Brain Tissue
B Lipinski, EM Sajdel-Sulkowska
Alzheimer Disease & Associated Disorders 2006
In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from γAsn319, Asp320 deletion dysfibrinogen, Otsu I
F Terasawa, S Kani, M Hongo, N Okumura
Thrombosis Research 2006
Fibrinogen Guarenas, an abnormal fibrinogen with an Aα-chain truncation due to a nonsense mutation at Aα 467 Glu (GAA)→stop (TAA)
R Marchi, Z Carvajal, M Meyer, J Soria, A Ruiz-Saez, CL Arocha-Piñango, JW Weisel
Thrombosis Research 2006
Les dysfibrinogènes
M Hanss
Revue Francophone des Laboratoires 2006
Modification of Fibrinogen by Homocysteine Thiolactone Increases Resistance to Fibrinolysis: A Potential Mechanism of the Thrombotic Tendency in Hyperhomocysteinemia
DL Sauls, E Lockhart, ME Warren, A Lenkowski, SE Wilhelm, M Hoffman
Biochemistry 2006
The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis
JP Collet, JL Moen, YI Veklich, OV Gorkun, ST Lord, G Montalescot, JW Weisel
Blood 2005
Natively unfolded regions of the vertebrate fibrinogen molecule
RF Doolittle, JM Kollman
Proteins: Structure, Function, and Genetics 2005
The mechanical properties of fibrin for basic scientists and clinicians
JW Weisel
Biophysical Chemistry 2004
Two novel fibrinogen variants found in patients with pulmonary embolism and their families
MM Hanss, PO Ffrench, JF Mornex, M Chabuet, F Biot, PD Mazancourt, M Dechavanne
Journal of Thrombosis and Haemostasis 2003
Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia
DL Sauls, AS Wolberg, M Hoffman
Journal of Thrombosis and Haemostasis 2003
Structure and function of human fibrinogen inferred from dysfibrinogens
M Matsuda, T Sugo
International Journal of Hematology 2002
Japanese Journal of Thrombosis and Hemostasis
M OKUDAIRA, H ASAKURA, Y SANO, Y SUGA, M YAMAZAKI, K AOSHIMA, E MORISHITA, M SAITO, Y ONTACHI, T MIZUTANI, M KATO, T ITO, K MIYAMOTO, S NAKAO
Japanese Journal of Thrombosis and Hemostasis 2001
Conformational Changes upon Conversion of Fibrinogen into Fibrin
L Medved, G Tsurupa, S Yakovlev
Annals of the New York Academy of Sciences 2001
Hereditary Disorders of Fibrinogen
M Matsuda, T Sugo
Annals of the New York Academy of Sciences 2001
The Structure and Function of the αC Domains of Fibrinogen
JW Weisel, L Medved
Annals of the New York Academy of Sciences 2001
Fibrinogen αC Domains Contain Cryptic Plasminogen and tPA Binding Sites
G Tsurupa, L Medved
Annals of the New York Academy of Sciences 2001
Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aα-chain, alters endothelial capillary tube formation
A Collen, A Maas, T Kooistra, F Lupu, J Grimbergen, FJ Haas, DH Biesma, P Koolwijk, J Koopman, VW van Hinsbergh
Blood 2001
Thrombotic Dysfibrinogenemia
R Marchi, SS Mirshahi, C Soria, M Mirshahi, M Zohar, JP Collet, NB de Bosch, CL Arocha-Piñango, J Soria
Thrombosis Research 2000
Structure and function of fibrinogen inferred from hereditary dysfibrinogens
M Matsuda
Fibrinolysis and Proteolysis 2000
Identification and Characterization of Novel tPA- and Plasminogen-Binding Sites within Fibrin(ogen) αC-Domains
G Tsurupa, L Medved
Biochemistry 2000
Familial thrombophilia associated with fibrinogen Paris V: Dusart syndrome
T Tarumi, D Martincic, A Thomas, R Janco, M Hudson, P Baxter, D Gailani
Blood 2000
End-linked homodimers in fibrinogen Osaka VI with a Bβ-chain extension lead to fragile clot structure
T Sugo, C Nakamikawa, N Yoshida, K Niwa, M Sameshima, J Mimuro, JW Weisel, A Nagita, M Matsuda
Blood 2000
A Novel Apolipoprotein A-1 Variant, Arg173Pro, Associated with Cardiac and Cutaneous Amyloidosis
KH Asl, JJ Liepnieks, M Nakamura, F Parker, MD Benson
Biochemical and Biophysical Research Communications 1999
Thermal conformational changes of bovine fibrinogen by differential scanning calorimetry and circular dichroism
Y Chen, H Mao, X Zhang, Y Gong, N Zhao
International Journal of Biological Macromolecules 1999
Fibrinogen Act chain mutation (Arg554 Leu) associated with hereditary renal amyloidosis in a French family
LH Asl, V Fournier, C Billerey, E Justrabo, D Chevet, D Droz, C Pécheux, M Delpech, G Grateau
Amyloid 1998
Factor XIIIa Cross-Linking of the Marburg Fibrin: Formation of αm·γn-Heteromultimers and the α-Chain–Linked Albumin·γ Complex, and Disturbed Protofibril Assembly Resulting in Acquisition of Plasmin Resistance Relevant to Thrombophila
T Sugo, C Nakamikawa, M Takebe, I Kohno, R Egbring, M Matsuda
Blood 1998
γ-Chain Dysfibrinogenemias: Molecular Structure-Function Relationships of Naturally Occurring Mutations in the γ Chain of Human Fibrinogen
HC Côté, S T., KP Pratt
Blood 1998
The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome"
MW Mosesson, KR Siebenlist, J Hainfeld, JS Wall, J Soria, C Soria, JP Caen
Journal of Clinical Investigation 1996
Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots
JP Collet, JL Woodhead, J Soria, C Soria, M Mirshahi, JP Caen, JW Weisel
Biophysical Journal 1996
The Ultrastructure of Fibrinogen Caracas II Molecules, Fibers, and Clots
JL Woodhead, C Nagaswami, M Matsuda, CL Arocha-Piñango, JW Weisel
The Journal of biological chemistry 1996
Factor XIIIa-Catalyzed Cross-Linking of Recombinant αC Fragments of Human Fibrinogen
YV Matsuka, LV Medved, MM Migliorini, KC Ingham
Biochemistry 1996
Factor IX Zutphen: a Cys18-->Arg mutation results in formation of a heterodimer with alpha 1-microglobulin and the inability to form a calcium-induced conformation
EG Wojcik, M Berg, IK van der Linden, SR Poort, R Cupers, RM Bertina
Biochemical Journal 1995
CLINICAL AND LABORATORY EVALUATION OF THE HYPERCOAGULABLE STATES
BG Macik, TL Ortel
Clinics in Chest Medicine 1995
Hereditary renal amyloidosis with a novel variant fibrinogen
T Uemichi, JJ Liepnieks, MD Benson
Journal of Clinical Investigation 1994
Pharmacological approaches of fibrin gel architecture modulation and thrombus degradation: Its implication in atherogenesis and thromboembolism disease
JP Collet, Z Mishal, M Vasse, M Mirshahi, JP Caen, C Soria, J Soria
Thrombosis Research 1994
11 The molecular genetics of familial venous thrombosis
DN Cooper
Baillière's Clinical Haematology 1994
Role of the .alpha.C Domains of Fibrin in Clot Formation
OV Gorkun, YI Veklich, LV Medved', AH Henschen, JW Weisel
Biochemistry 1994
Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin
C Legrand, V Morandi, S Mendelovitz, H Shaked, JR Hartman, A Panet
Arteriosclerosis Thrombosis and Vascular Biology 1994
A frameshift mutation in Exon V of the A alpha-chain gene leading to truncated A alpha-chains in the homozygous dysfibrinogen Milano III
M Furlan, C Steinmann, M Jungo, C Bögli, F Baudo, R Redaelli, F Fedeli, B Lämmle
The Journal of biological chemistry 1994
Letter to the editor
MA Gillman, FJ Lightigfeld
PAIN 1981

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts